Search clinical trials for: solid tumor malignancy; Hsp90
Total 33408 results
-
Protgen LtdUnknown
-
Protgen LtdUnknownColorectal CancerChina
-
Esanex Inc.Completed
-
Esanex Inc.National Cancer Institute (NCI)CompletedLymphoma | Leukemia | Solid Tumor Malignancy | Lymphoid Malignancy (Lymphoma and CLL)United States
-
Esanex Inc.Completed
-
Sarcoma Alliance for Research through CollaborationUnited States Department of Defense; Synta Pharmaceuticals Corp.CompletedSarcoma | Malignant Peripheral Nerve Sheath Tumors (MPNST)United States
-
Esanex Inc.Completed
-
Herbert LyerlyTerminatedSolid TumorUnited States
-
Myrexis Inc.Completed
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompleted
-
Bristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
Dale Shepard, MD, PhDNational Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Esanex Inc.TerminatedCancerUnited States
-
Esanex Inc.Completed
-
Infinity Pharmaceuticals, Inc.Terminated
-
Esanex Inc.Completed
-
Bristol-Myers SquibbCompletedMultiple MyelomaUnited States, Canada
-
Novartis PharmaceuticalsCompleted
-
Herbert LyerlyWithdrawnSolid TumorUnited States
-
Esanex Inc.Pfizer; Serenex, Inc.Completed
-
BiogenCompletedLymphoma | TumorsUnited Kingdom, United States
-
Protgen LtdUnknown
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomUnknownAdvanced Solid MalignanciesUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterNovartisTerminated
-
Novartis PharmaceuticalsTerminatedAdvanced Gastric CancerSpain, Belgium, France, Italy, United States, Korea, Republic of, Japan, Germany
-
National Cancer Institute (NCI)Terminated
-
SCRI Development Innovations, LLCNovartis PharmaceuticalsCompletedMetastatic or Unresectable Solid Tumor MalignancyUnited States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedMultiple MyelomaUnited States, Philippines, United Kingdom
-
M.D. Anderson Cancer CenterNovartisTerminated
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
-
Novartis PharmaceuticalsCompletedBreast Cancer | Hematologic NeoplasmsNetherlands, Switzerland, United Kingdom, United States
-
David M. Jackman, MDMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Synta Pharmaceuticals...CompletedSmall Cell Lung CancerUnited States
-
BiogenTerminatedB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Astex Pharmaceuticals, Inc.CompletedMetastatic Solid TumorsUnited States
-
Esanex Inc.Serenex, Inc.CompletedHematologic NeoplasmsUnited States
-
Debiopharm International SACompletedNeoplasms | Lymphoma | Cancer | Solid TumorsFrance
-
ARCIM Institute Academic Research in Complementary...RecruitingChemotherapy-induced Peripheral Neuropathy (CIPN)Germany
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesFrance, Spain, Canada
-
Synta Pharmaceuticals Corp.CompletedSolid Tumor MalignanciesUnited States
-
National Cancer Institute (NCI)Completed
-
BiogenTerminatedChronic Lymphocytic LeukemiaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Infinity Pharmaceuticals, Inc.TerminatedLung Cancer | Stage IV Lung Cancer | Stage IIIb Lung CancerUnited States
-
Novartis PharmaceuticalsCompletedNon-small-cell Lung CancerCanada, France, Spain, Netherlands, Singapore, Germany, Korea, Republic of, Turkey, United States, Norway
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.; ExelixisActive, not recruitingMelanoma | Skin CancerUnited States
-
Emory UniversitySynta Pharmaceuticals Corp.TerminatedStage IVA Oral Cavity Squamous Cell Carcinoma | Stage IVA Laryngeal Squamous Cell Carcinoma | Stage IVA Oropharyngeal Squamous Cell Carcinoma | Stage I Hypopharyngeal Squamous Cell Carcinoma | Stage I Laryngeal Squamous Cell Carcinoma | Stage I Oropharyngeal Squamous Cell Carcinoma | Stage II... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
Debiopharm International SASyneos HealthTerminatedNon-small Cell Lung CancerSpain, France, United Kingdom
-
University Medical Center GroningenCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteExelixisCompleted